首页> 美国卫生研究院文献>Integrative Cancer Therapies >Impact of Oncological Therapy and Viscum album LTreatment on Cancer-Related Fatigue and Internal Coherence in NonmetastasizedBreast Cancer Patients
【2h】

Impact of Oncological Therapy and Viscum album LTreatment on Cancer-Related Fatigue and Internal Coherence in NonmetastasizedBreast Cancer Patients

机译:肿瘤治疗和粘性专辑L的影响癌症相关疲劳和内部连贯性在非系列中的治疗方法乳腺癌患者

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Introduction:Viscum album L extracts (VA) are frequently used in integrativeoncology. Aim of this study was to evaluate the impact of add-on VA applicationson various patient-reported outcome measures. Methods: Alongitudinal real-world study was conducted, using data from the NetworkOncology clinical registry. Primary, nonmetastasized breast cancer patientstreated with oncological standard therapy partly combined with VA applicationswere included. Internal Coherence Cancer-related Fatigue, and EORTC QLQ-C30questionnaires were assessed at baseline and 6, 12, and 24 months later.Results: A total of 319 patients received standard oncologicaltherapy and 40% of them additionally VA applications. After 6 and 12 months forpatients treated with chemotherapy (Ctx) only a significant decline of thethermo-coherence, and worsening of fatigue was observed. For patients receivingVA applications but no Ctx, significant beneficial effects on thermo-coherence,fatigue, and seven EORTC QLQ-C30 scales were observed 24 months later. Adjustedmultivariable long-term subgroup (n = 106) regression analysisrevealed that Ctx, immuno-, and endocrine therapies had a worsening of 17, 17,and 6 point changes, respectively, for EORTC QLQ-C30 fatigue (P= .0004), while VA applications showed an improvement of 12 point change. Asimilar impact of improvement (add-on VA) and worsening (standard oncologicaltreatment regimens) on EORTC QLQ-C30 insomnia (P = .009) andphysical functioning (P = .005) were observed.Conclusions: In the present real-world study, add-on VAapplications had a supportive effect on cancer-related fatigue, insomnia,physical functioning, and thermo-coherence. Thus, VA applications might besuited to alleviate symptom burden during anticancer therapy in breast cancerpatients.
机译:介绍:Viscum专辑L提取物(VA)经常用于整合肿瘤学。本研究的目的是评估附加VA应用的影响论各种患者报告的结果措施。方法:A使用来自网络的数据进行纵向真实研究肿瘤学临床登记处。原发性,非容性性乳腺癌患者用肿瘤标准疗法治疗,部分结合VA应用包括在内。内部连贯性癌症相关疲劳,EORTC QLQ-C30问卷在基线和6,12和24个月内评估。结果:共有319名患者接受标准肿瘤治疗和其中40%的申请。 6和12个月后患者用化疗(CTX)治疗(CTX)只有显着下降观察到疲劳和疲劳恶化。对于接受患者的患者VA应用但没有CTX,对热敏的显着有益效果,24个月后观察到疲劳和七个EORTC QLQ-C30秤。调整多变量长期子组(n = 106)回归分析揭示CTX,免疫和内分泌疗法的恶化为17,17,对于EORTC QLQ-C30疲劳,分别为6点变​​化(P= .0004),而VA应用程序显示12点变化的提高。一种改善(附加VA)和恶化的类似影响(标准肿瘤治疗方案)在EORTC QLQ-C30失眠(P = .009)和观察到物理功能(p = .005)。结论:在目前的真实研究中,附加VA应用对癌症相关的疲劳,失眠,失眠物理功能,以及热干性。因此,VA应用程序可能是适合缓解患者患有抗癌治疗的症状负担耐心。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号